HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matti Aapro Selected Research

Etoposide (VP 16)

1/2021Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matti Aapro Research Topics

Disease

71Neoplasms (Cancer)
12/2023 - 01/2002
53Nausea
03/2024 - 01/2004
53Vomiting
12/2023 - 01/2004
31Breast Neoplasms (Breast Cancer)
04/2024 - 01/2002
18Anemia
01/2019 - 10/2006
15Febrile Neutropenia
01/2022 - 02/2008
12Neutropenia
02/2024 - 06/2010
10Chemotherapy-Induced Febrile Neutropenia
06/2019 - 05/2010
9Neoplasm Metastasis (Metastasis)
06/2019 - 03/2007
4Fatigue
01/2021 - 08/2014
4Prostatic Neoplasms (Prostate Cancer)
10/2017 - 04/2012
4Osteonecrosis (Kienbock's Disease)
10/2012 - 03/2007
3Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 01/2017
3Alopecia (Baldness)
01/2021 - 04/2016
3Multiple Myeloma
04/2012 - 01/2010
2COVID-19
01/2022 - 01/2021
2Dyspnea (Shortness of Breath)
01/2021 - 06/2019
2Infections
01/2021 - 10/2017
2Hypersensitivity (Allergy)
01/2021 - 01/2020
2Hemorrhage
01/2021 - 04/2011
2Hematologic Neoplasms (Hematological Malignancy)
12/2019 - 03/2019
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2019 - 05/2007
2Hypertension (High Blood Pressure)
06/2019 - 05/2011
2Disease Progression
06/2019 - 01/2002
2Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2018 - 03/2018
2Iron Deficiencies
12/2015 - 01/2014
2Osteoporosis
08/2014 - 04/2012
1Chronic Kidney Failure (Chronic Renal Failure)
01/2023
1Sepsis (Septicemia)
01/2021
1Injection Site Reaction
01/2021

Drug/Important Bio-Agent (IBA)

26AntiemeticsIBA
03/2024 - 01/2004
22Biosimilar PharmaceuticalsIBA
04/2024 - 03/2011
17Palonosetron (Aloxi)FDA Link
03/2024 - 01/2004
16Dexamethasone (Maxidex)FDA LinkGeneric
03/2024 - 02/2005
14Filgrastim (Neupogen)FDA Link
02/2024 - 03/2011
14AnthracyclinesIBA
01/2021 - 01/2002
14Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 02/2003
9Cisplatin (Platino)FDA LinkGeneric
03/2024 - 01/2008
9netupitantIBA
03/2024 - 01/2015
9Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2022 - 02/2008
9HematinicsIBA
01/2019 - 02/2007
6Epoetin Alfa (Epogen)FDA Link
01/2023 - 01/2014
6Aprepitant (Emend)FDA Link
01/2023 - 01/2004
65-HT3 Serotonin Receptors (5 HT3 Receptor)IBA
01/2021 - 01/2004
5Hormones (Hormone)IBA
01/2022 - 04/2011
5Neurokinin-1 Receptor AntagonistsIBA
01/2021 - 04/2016
5Diphosphonates (Bisphosphonates)IBA
04/2012 - 03/2007
5epoetin betaIBA
11/2009 - 01/2004
4pegfilgrastim (Neulasta)FDA Link
06/2020 - 06/2010
4taxaneIBA
06/2019 - 01/2004
4Adrenal Cortex Hormones (Corticosteroids)IBA
01/2017 - 06/2005
4IronIBA
11/2016 - 01/2014
4Zoledronic Acid (Zometa)FDA Link
04/2012 - 03/2007
3human ERBB2 proteinIBA
04/2024 - 01/2022
3Olanzapine (Zyprexa)FDA Link
08/2021 - 03/2020
3Colony-Stimulating Factors (Colony Stimulating Factor)IBA
06/2019 - 05/2010
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017 - 02/2003
3Serotonin (5 Hydroxytryptamine)IBA
01/2017 - 07/2005
3Granisetron (Kytril)FDA LinkGeneric
08/2016 - 01/2004
3DenosumabFDA Link
04/2012 - 01/2010
3Docetaxel (Taxotere)FDA Link
10/2011 - 01/2002
3Proteins (Proteins, Gene)FDA Link
07/2010 - 02/2007
2Trastuzumab (Herceptin)FDA Link
04/2024 - 02/2004
2Antineoplastic Agents (Antineoplastics)IBA
12/2023 - 01/2014
2Carboplatin (JM8)FDA LinkGeneric
01/2021 - 08/2016
2Paclitaxel (Taxol)FDA LinkGeneric
06/2019 - 10/2011
2Vinorelbine (Navelbine)FDA LinkGeneric
06/2019 - 04/2012
2AntibodiesIBA
10/2017 - 01/2017
2RadiopharmaceuticalsIBA
01/2017 - 05/2012
2Substance PIBA
01/2017 - 06/2005
2rolapitantIBA
01/2017 - 08/2016
2Hemoglobins (Hemoglobin)IBA
04/2013 - 10/2006
2CreatinineIBA
05/2012 - 03/2012
2Aromatase InhibitorsIBA
04/2011 - 07/2007
2Pamidronate (Aredia)FDA LinkGeneric
01/2010 - 03/2007
2Vincristine (Oncovin)FDA LinkGeneric
01/2009 - 02/2003
2liposomal doxorubicin (Doxil)FDA Link
04/2008 - 01/2007
2ErythropoietinFDA Link
02/2008 - 01/2004
2Capecitabine (Xeloda)FDA Link
01/2002 - 01/2002
1OgivriIBA
04/2024
1EmeticsIBA
12/2023
1ErbB Receptors (EGF Receptor)IBA
12/2022
1phytobacteriomycin (PBM)IBA
01/2022
1Phenobarbital (Luminal)FDA Link
01/2022
1PlatinumIBA
01/2021
1Etoposide (VP 16)FDA LinkGeneric
01/2021
1Topotecan (Hycamtin)FDA LinkGeneric
01/2021
1trilaciclibIBA
01/2021

Therapy/Procedure

101Drug Therapy (Chemotherapy)
03/2024 - 01/2002
37Therapeutics
12/2022 - 01/2002
7Radiotherapy
01/2023 - 01/2002
4Adjuvant Chemotherapy
06/2019 - 06/2005
3Palliative Care (Palliative Therapy)
01/2021 - 12/2017
2Hematopoietic Stem Cell Mobilization
02/2024 - 12/2019
2Chemoradiotherapy
01/2019 - 01/2008
2Activities of Daily Living (ADL)
12/2017 - 10/2017
2Castration
10/2017 - 01/2017
2Combination Drug Therapy (Combination Chemotherapy)
01/2008 - 07/2004
1Length of Stay
01/2022
1Ambulatory Care (Outpatient Care)
01/2022